1. Home
  2. Medical News
  3. Optometry

Lumenis’ OptiPlus Dual-Frequency RF Energy Device Launched

11/06/2023
Lumenis’ OptiPlus Dual-Frequency RF Energy Device Launched image

Lumenis announced the launch of the OptiPlus dual-frequency radiofrequency (RF) device, which is designed to deliver heat across different tissue layers, thus increasing blood circulation to promote medical performance and aesthetic results.

According to the company, OptiPlus is a complementary device to the Lumenis OptiLight technology, which targets the root cause of dry eye disease.

The company said that OptiLight relies on a light-based technology to break the cycle of dry-eye inflammation caused by meibomian gland dysfunction. OptiPlus is a dedicated device that employs an RF energy to enhance clinical results. The FDA-cleared technology enables energy penetration to different skin depths, heating the superficial layer to promote collagen formation and stimulate peri-orbital skin rejuvenation while also reaching into the deeper tissue to target the meibomian glands, stated the company.

The device features a monopolar electrode that ensures optimized contact with the delicate contours in the periorbital area, enabling safety and patient comfort. OptiPlus is intended for treatment of patients across a range of skin types. The state-of-the-art technology includes clinically validated, pre-embedded settings and temperature control for efficacy and safety.

“I’m very pleased with the clinical outcomes experienced while using OptiLight to treat dry eye disease, and I’m excited about incorporating OptiPlus as an essential addition to my armamentarium,” commented James Chelnis, MD, in the company’s press releasee. Dr. Chelnis, who is an ophthalmologist at Manhattan Face & Eye in New York, New York, continued, “As the leading investigator in a recently published clinical study, I discovered that the pairing of these two technologies brings remarkable results, significantly improving the number of expressible meibomian glands (over 150%, average), meibum clarity (over 70%) and symptoms (over 60%). The fact that it also offers aesthetic benefits is just another great advantage.”

Register

We're glad to see you're enjoying Modern Optometry…
but how about a more personalized experience?

Register for free